Sunstone Life Science Ventures
Investor profile
Venture capital
Also recorded as: Sunstone LifeScience Ventures
Deals
6
distinct rounds
Companies
5
backed
Active span
2020–2024
5 yrs
Total round €
€183M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Adjuvant Capital2
- Andera Partners2
- Curie Capital2
- First Venture2
- FundPlus2
- Hadean Ventures2
- Industrifonden2
- INKEF Capital2
- LF Investment2
- Sanofi Ventures2
- Trill Impact Ventures2
- Utrecht Health Seed Fund2
- Wellington Partners2
- Claris Ventures1
- EQT Life Sciences1
- Kurma Partners1
- Novo Holdings1
- OrbiMed1
- Pureos Bioventures1
- Pureos Ventures1
- Repair Impact Fund1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| MinervaX | Denmark | 2 | €76M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| Synendos Therapeutics | Switzerland | 1 | €19M |
| Resalis Therapeutics | Italy | 1 | €10M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| MinervaX | Other | €54M | 2023-10 |
| TargED Biopharmaceutical | Series A | €39M | 2022-02 |
| TargED Biopharmaceuticals | Series A | €39M | 2022-02 |
| MinervaX | Other | €22M | 2022-12 |
| Synendos Therapeutics | Series A | €19M | 2020-11 |
| Resalis Therapeutics | Series A | €10M | 2024-01 |